TY  - GEN
AU  - Seitz,M
AU  - Wirthmüller,U
AU  - Möller,B
AU  - Villiger,P M
TI  - The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients
SN  - 1462-0324
PY  - 2007///0330
KW  - Adalimumab
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antirheumatic Agents
KW  - Arthritis, Psoriatic
KW  - drug therapy
KW  - Arthritis, Rheumatoid
KW  - Etanercept
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Immunoglobulin G
KW  - Infliximab
KW  - Male
KW  - Middle Aged
KW  - Polymorphism, Genetic
KW  - Prognosis
KW  - Promoter Regions, Genetic
KW  - Receptors, Tumor Necrosis Factor
KW  - Severity of Illness Index
KW  - Spondylitis, Ankylosing
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/rheumatology/kel175
ER  -